Amicus Therapeutics
FOLD
#3908
Rank
ยฃ2.29 B
Marketcap
ยฃ7.43
Share price
-0.50%
Change (1 day)
-2.85%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): ยฃ3.88 Million

According to Amicus Therapeutics 's latest financial reports the company's current earnings are ยฃ0.59 Billion. In 2024 the company made an earning of -ยฃ21.59 Million, an increase over its 2023 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ3.88 M-117.98%
2024 -ยฃ21.59 Million-80.84%
2023 -ยฃ0.12 Billion-37.98%
2022 -ยฃ0.19 Billion0.2%
2021 -ยฃ0.19 Billion-11.92%
2020 -ยฃ0.21 Billion-22.94%
2019 -ยฃ0.27 Billion1.95%
2018 -ยฃ0.27 Billion-22.27%
2017 -ยฃ0.34 Billion120.39%
2016 -ยฃ0.16 Billion54.24%
2015 -ยฃ99.18 Million88.63%
2014 -ยฃ52.58 Million10.92%
2013 -ยฃ47.4 Million21.36%
2012 -ยฃ39.06 Million8.3%
2011 -ยฃ36.07 Million-14.33%
2010 -ยฃ42.1 Million753.76%
2009 -ยฃ4.94 Million-83.31%
2008 -ยฃ29.55 Million-4.4%
2007 -ยฃ30.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
ยฃ1.42 B 38,117.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B 13,534.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.6 Million-650.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ6.99 B 187,031.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-ยฃ51.48 Million-1,476.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
ยฃ15.64 B 418,322.32%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark